Appendix cancer, once rare, is now rising sharply among younger people. Firstpost brings out an expert’s views on the risk ...

The number of colorectal cancer cases in people under 50 is rising worldwide, especially in high-income countries. Possible ...

Colon cancer is the second leading cause of cancer-related deaths globally. This cancer often develops silently, with symptoms emerging only in later stages. Early detection can significantly ...

The American Cancer Society (ACS) estimates 154,000 individuals will be diagnosed with new cases of colorectal cancer in 2025 — including 107,000 cases of colon cancer and 47,000 cases of rectal ...

Tumors shrank more with the addition of acoustic cluster therapy to chemotherapy in colorectal liver metastases in the phase 1 ACTIVATE trial. As a Lynch syndrome previvor, I feel deep gratitude to ...

Bowel cancer, also known as colorectal cancer, accounts for approximately 10% of all cancer cases. It is the second leading cause of cancer-related deaths worldwide. Bowel cancer predominantly ...

New blood tests can detect cancer recurrence earlier than traditional scans, potentially giving doctors and patients crucial information to make decisions about treatment. But more studies are needed ...

Adding Roche's immunotherapy drug Tecentriq to chemotherapy after surgery in certain patients whose colon cancer had spread to the lymph nodes led to a 50% reduction in cancer recurrence and death ...

CHICAGO — In this video, Jennifer A. Ligibel, MD, discusses the phase 3 CHALLENGE study evaluating the impact of structured exercise on disease-free survival for stage 3 or high-risk stage 2 ...

"Early-onset colorectal cancer is a growing global phenomenon, But, at the same time, it is still rare," said Dr Yin Cao from Washington University in St Louis, one of the researchers behind the work.

Loss of cadherin 17 downregulates LGR5 expression, stem cell properties and drug resistance in metastatic colorectal cancer cells Ruben A. Bartolomé Laura Pintado-Berninches J. Ignacio Casal ...